The pleasures and pains of mephedrone use: Perceptions of users and practitioners

References

• Advisory Council on the Misuse of Drugs. (2010). Consideration of the cathinones. London: Advisory Council on the Misuse of Drugs
   Google Scholar
• Brunt, T.M., Poortman, A., Niesink, R.J.M., & van den Brink, W. (2011). Instability of the ecstasy market and a new kid on the block: Mephedrone. Journal of Psychopharmacology, 25, 1543–1547. doi: 10.1177/0269881110378370
   PubMed Web of Science ®Google Scholar
• Carhart-Harris, R.L., King, L.A., & Nutt, D.J. (2011). A web-based survey on mephedrone. Drug and Alcohol Dependence, 118, 19–22. doi: 10.1016/j.drugalcdep.2011.02.011
   PubMed Web of Science ®Google Scholar
• Corkery, J.M., Schifano, F., & Hamid Ghodse, A. (2012). Mephedrone-related fatalities in the United Kingdom: Contextual, clinical and practical issues. In L. Gallelli (Ed.), Pharmacology. London: InTech, 355–380
   Google Scholar
• Dargan, P., Albert, S., & Wood, D. (2010). Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change. Quarterly Journal of Medicine, 103, 875–872
   Google Scholar
• Department of Health (England) and the Devolved Administrations. (2007). Drug misuse and dependence: UK guidelines on clinical management. London: Department of Health (England), The Scottish Government, Welsh Assembly Government and Northern Ireland Executive
   Google Scholar
• EMCDDA. (2011). Report on the risk assessment of mephedrone in the framework of the Council Decision on new psychoactive substances. Luxembourg: Publications Office of the European Union
   Google Scholar
• Freeman, T.P., Morgan, C.J.A., Vaughn-Jones, J., Hussain, N., Karimi, K., & Curran, H.V. (2012). Cognitive and subjective effects of mephedrone and factors influencing use of a ‘new legal high’. Addiction, 107, 792–800. doi: 10.1111/j.1360-0443.2011.03719.x
   PubMed Web of Science ®Google Scholar
• Health and Social Care Committee. (2015). Inquiry into new psychoactive substances. Cardiff: National Assembly for Wales
   Google Scholar
• Kapitány-Fövény, M., Kertész, M., Winstock, A.R., Deluca, P., Corazza, O., Farkas, J… Demetrovics, Z. (2013). Substitutional potential of mephedrone: An analysis of the subjective effects. Human Psychopharmacology: Clinical and Experimental, 28, 308–316. doi: 10.1002/hup.2297
   PubMed Web of Science ®Google Scholar
• Kasick, D.P., McKnight, C.A., & Klisovic, E. (2012). “Bath Salt” ingestion leading to severe intoxication delirium: Two cases and a brief review of the emergence of mephedrone use. The American Journal of Drug and Alcohol Abuse, 38, 176–180
   PubMed Web of Science ®Google Scholar
• Mackay, K., Taylor, M., & Bajaj, N. (2011). The adverse consequences of mephedrone use: A case series. The Psychiatrist, 35, 203–205
   Google Scholar
• Matthews, A.J., & Bruno, R. (2010) Mephedrone use among regular ecstasy consumers in Australia: EDRS Drug Trends Bulletin. Sydney: National Drug and Alcohol Research Centre, University of New South Wales
   Google Scholar
• McElrath, K., & O’Neill, C. (2011). Experiences with mephedrone pre- and post-legislative controls: Perceptions of safety and sources of supply. International Journal of Drug Policy, 22, 120–127
   PubMed Web of Science ®Google Scholar
• Measham, F., Moore, K., Newcombe, R., & Welch, Z. (2010). Tweaking, bombing, dabbing and stockpiling: The emergence of mephedrone and the perversity of prohibition. Drugs and Alcohol Today, 10, 14–21
   Google Scholar
• Miotto, K., Striebel, J., Cho, A.K., & Wang, C. (2013). Clinical and pharmacological aspects of bath salt use: A review of the literature and case reports. Drug and Alcohol Dependence, 132, 1–12
   PubMed Web of Science ®Google Scholar
• Newcombe, R. (2009). The use of mephedrone (M-Cat, Meow) in Middlesborough. Manchester: Lifeline Publications and Research Ed
   Google Scholar
• Norman, J., Grace, S., & Lloyd, C. (2014). Legal high groups on the internet The creation of new organized deviant groups? Drugs: Education, Prevention and Policy, 21, 14–23. doi: 10.3109/09687637.2013.769500
   Web of Science ®Google Scholar
• Nutt, D.J. (2012). Drugs – without the hot air: Minimising the harms of legal and illegal drugs. Cambridge: UIT
   Google Scholar
• Nutt, D.J., King, L.A., & Phillips, L. (2010). Drug harms in the UK: A multicriteria decision analysis. The Lancet (London, England), 376, 1558–1565
   PubMed Web of Science ®Google Scholar
• Nutt, D.J., King, L.A., Saulsbury, W., & Blakemore, C. (2007). Development of a rational scale to assess the harm of drugs of potential misuse. The Lancet, 369, 1047–1053
   PubMed Web of Science ®Google Scholar
• Pennay, A. (2015). “What goes up must go down”: An exploration of the relationship between drug-related pleasure and harm experienced by a sample of regular “party drug” users. Drugs: Education, Prevention and Policy, 22, 185–192
   Web of Science ®Google Scholar
• Psychonaut Web Mapping Research Group. (2009). Mephedrone report. London: Institute of Psychiatry
   Google Scholar
• van Hout, M., & Brennan, R. (2011). Plant food for thought: A qualitative study of mephedrone use in Ireland. Drugs: Education, Prevention and Policy, 18, 371–381
   Web of Science ®Google Scholar
• Winstock, A.R., & Marsden, J. (2010). Mephedrone: Assessment of health risks and harms. Risk assessment report of a new psychoactive substance: 4-Methylmethcathinone (mephedrone). Lisbon
   Google Scholar
• Winstock, A.R., Marsden, J., & Mitcheson, L. (2010). What should be done about mephedrone? BMJ, 340, 23–44. doi: 10.1136/bmj.c1605
   Web of Science ®Google Scholar
• Winstock, A.R., Mitcheson, L.R., Deluca, P., Davey, Z., Corazza, O., & Schifano, F. (2011). Mephedrone, new kid for the chop? Addiction (Abingdon, England), 106, 154. doi: 10.1111/j.1360-0443.2010.03130.x
   PubMed Web of Science ®Google Scholar